Clinical Trials Browser

Observational × Carcinoma, Hepatocellular × Tyrosine Kinase Inhibitors × Clear all

NCT06632106 2024-10-08

HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular